Svecla M, Moregola A, Da Dalt L, Nour J, Baragetti A, Uboldi P
Cardiovasc Diabetol. 2024; 23(1):428.
PMID: 39616371
PMC: 11608471.
DOI: 10.1186/s12933-024-02507-5.
Cao Z, Zhang Z, Wang Y, Zhu Y, Li Z, Li X
Heliyon. 2024; 10(16):e35908.
PMID: 39211922
PMC: 11357755.
DOI: 10.1016/j.heliyon.2024.e35908.
Visconti A, Rossi N, Bondt A, Ederveen A, Thareja G, Koeleman C
Genome Med. 2024; 16(1):96.
PMID: 39123268
PMC: 11312925.
DOI: 10.1186/s13073-024-01369-6.
Bladergroen M, Pongracz T, Wang W, Nicolardi S, Arbous S, Roukens A
iScience. 2024; 27(7):110374.
PMID: 39100929
PMC: 11294702.
DOI: 10.1016/j.isci.2024.110374.
Pongracz T, Mayboroda O, Wuhrer M
JACS Au. 2024; 4(5):1696-1708.
PMID: 38818049
PMC: 11134357.
DOI: 10.1021/jacsau.4c00043.
Erythropoietin -glycosylation of Therapeutic Formulations Quantified and Characterized: An Interlab Comparability Study of High-Throughput Methods.
OFlaherty R, Amez Martin M, Gardner R, Jennings P, Rudd P, Spencer D
Biomolecules. 2024; 14(1).
PMID: 38254725
PMC: 10813422.
DOI: 10.3390/biom14010125.
Glycomics studies using sialic acid derivatization and mass spectrometry.
de Haan N, Yang S, Cipollo J, Wuhrer M
Nat Rev Chem. 2023; 4(5):229-242.
PMID: 37127981
DOI: 10.1038/s41570-020-0174-3.
Nomograms Based on Serum -glycome for Diagnosis of Papillary Thyroid Microcarcinoma and Prediction of Lymph Node Metastasis.
Zhang Z, Cao Z, Liu R, Li Z, Wu J, Liu X
Curr Oncol. 2022; 29(9):6018-6034.
PMID: 36135043
PMC: 9497917.
DOI: 10.3390/curroncol29090474.
High-Throughput Glycomic Methods.
Trbojevic-Akmacic I, Lageveen-Kammeijer G, Heijs B, Petrovic T, Deris H, Wuhrer M
Chem Rev. 2022; 122(20):15865-15913.
PMID: 35797639
PMC: 9614987.
DOI: 10.1021/acs.chemrev.1c01031.
Developments and perspectives in high-throughput protein glycomics: enabling the analysis of thousands of samples.
de Haan N, Pucic-Bakovic M, Novokmet M, Falck D, Lageveen-Kammeijer G, Razdorov G
Glycobiology. 2022; 32(8):651-663.
PMID: 35452121
PMC: 9280525.
DOI: 10.1093/glycob/cwac026.
Validation of diagnostic and predictive biomarkers for hereditary angioedema via plasma N-glycomics.
Zhang Z, Wang X, Gu J, Wu J, Cao Y, Xu Y
Clin Transl Allergy. 2021; 11(10):e12090.
PMID: 34962719
PMC: 8712629.
DOI: 10.1002/clt2.12090.
Mass spectrometry in clinical glycomics: The path from biomarker identification to clinical implementation.
de Haan N, Wuhrer M, Ruhaak L
Clin Mass Spectrom. 2021; 18:1-12.
PMID: 34820521
PMC: 8600986.
DOI: 10.1016/j.clinms.2020.08.001.
Plasma protein glycosylation is associated with cardiovascular disease, nephropathy, and retinopathy in type 2 diabetes.
Memarian E, t Hart L, Slieker R, Lemmers R, van der Heijden A, Rutters F
BMJ Open Diabetes Res Care. 2021; 9(1).
PMID: 34645615
PMC: 8515459.
DOI: 10.1136/bmjdrc-2021-002345.
Mass Spectrometry-Based Techniques to Elucidate the Sugar Code.
Grabarics M, Lettow M, Kirschbaum C, Greis K, Manz C, Pagel K
Chem Rev. 2021; 122(8):7840-7908.
PMID: 34491038
PMC: 9052437.
DOI: 10.1021/acs.chemrev.1c00380.
The fate of orally administered sialic acid: First insights from patients with -acetylneuraminic acid synthase deficiency and control subjects.
Tran C, Turolla L, Ballhausen D, Cornaz Buros S, Teav T, Gallart-Ayala H
Mol Genet Metab Rep. 2021; 28:100777.
PMID: 34258226
PMC: 8251509.
DOI: 10.1016/j.ymgmr.2021.100777.
Distinguishing Benign and Malignant Thyroid Nodules and Identifying Lymph Node Metastasis in Papillary Thyroid Cancer by Plasma -Glycomics.
Zhang Z, Reiding K, Wu J, Li Z, Xu X
Front Endocrinol (Lausanne). 2021; 12:692910.
PMID: 34248851
PMC: 8267918.
DOI: 10.3389/fendo.2021.692910.
Glycan Imaging Mass Spectrometry: Progress in Developing Clinical Diagnostic Assays for Tissues, Biofluids, and Cells.
Blaschke C, McDowell C, Black A, Mehta A, Angel P, Drake R
Clin Lab Med. 2021; 41(2):247-266.
PMID: 34020762
PMC: 8862151.
DOI: 10.1016/j.cll.2021.03.005.
Serum N-glycan profiles differ for various breast cancer subtypes.
Vreeker G, Vangangelt K, Bladergroen M, Nicolardi S, Mesker W, Wuhrer M
Glycoconj J. 2021; 38(3):387-395.
PMID: 33877489
PMC: 8116229.
DOI: 10.1007/s10719-021-10001-3.
Quantitative clinical glycomics strategies: A guide for selecting the best analysis approach.
Patabandige M, Pfeifer L, Nguyen H, Desaire H
Mass Spectrom Rev. 2021; 41(6):901-921.
PMID: 33565652
PMC: 8601598.
DOI: 10.1002/mas.21688.
Meta-heterogeneity: Evaluating and Describing the Diversity in Glycosylation Between Sites on the Same Glycoprotein.
Caval T, Heck A, Reiding K
Mol Cell Proteomics. 2021; 20:100010.
PMID: 33561609
PMC: 8724623.
DOI: 10.1074/mcp.R120.002093.